Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Synthesis of Epstein-Barr Virus after Activation of the Viral Genome in a "Virus-Negative" Human Lymphoblastoid Cell (Raji) Made Resistant to 5-bromodeoxyuridine

Berge Hampar, Jeffery G. Derge, Lidia M. Martos and John L. Walker
Proceedings of the National Academy of Sciences of the United States of America
Vol. 69, No. 1 (Jan., 1972), pp. 78-82
Stable URL: http://www.jstor.org/stable/60984
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Synthesis of Epstein-Barr Virus after Activation of the Viral Genome in a "Virus-Negative" Human Lymphoblastoid Cell (Raji) Made Resistant to 5-bromodeoxyuridine
Preview not available

Abstract

The Raji line of human lymphoblastoid cells, which does not show expression of Epstein-Barr virus, was made resistant to 5-bromodeoxyuridine. Within several weeks after removal of the drug, Epstein-Barr virus particles were detected in the cells. The sequence of virus appearance in the 5-bromodeoxyuridine-resistant cells indicated drug-induced activation of a repressed Epstein-Barr virus genome.

Page Thumbnails

  • Thumbnail: Page 
78
    78
  • Thumbnail: Page 
79
    79
  • Thumbnail: Page 
80
    80
  • Thumbnail: Page 
81
    81
  • Thumbnail: Page 
82
    82